Astra lifts earnings target

Drugs giant AstraZeneca today upped its earnings guidance for the year after reporting a better-than-expected hike in third quarter profits.

The group said pre-tax profits rose to $2.44bn (€1.9bn) in the three months to the end of September, up 29%, helped by currency movements.